News
It steers clear of those issuers without a long record of underwriting rigor and consistency when buying bonds or securitized products ... remains with BBH as a limited partner.
Hosted on MSN18d
Should You Invest in the VanEck Biotech ETF (BBH)?BBH seeks to match the performance of the MVIS ... Annual operating expenses for this ETF are 0.35%, making it one of the least expensive products in the space. It has a 12-month trailing dividend ...
It steers clear of those issuers without a long record of underwriting rigor and consistency when buying bonds or securitized products ... remains with BBH as a limited partner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results